期刊文献+

TNF-α及IL-8检测在慢性阻塞性肺疾病中的意义 被引量:5

Significance of detecting TNF-α and IL-8 in chronic obstructive pulmonary disease
暂未订购
导出
摘要 目的:探讨肿瘤坏死因子-α(TNF-α)及白介素-8(IL-8)在慢性阻塞性肺疾病(COPD)发病机制中的作用。方法:收集28例COPD急性加重期患者,25例COPD缓解期患者和30例健康者的静脉血,离心后取血清,采用酶联免疫法(ELISA)测定其中TNF-α及IL-8水平,同时对COPD急性期患者常规测定动脉血PaO2、PaCO2。结果:COPD急性加重期患者血清TNF-α及IL-8水平明显高于缓解期及健康对照组,缓解期明显高于对照组(P<0.05);COPD急性加重期血中TNF-α及IL-8含量与PaO2成负相关,与PaCO2呈正相关。结论:TNF-α及IL-8参与了COPD气道炎性反应,TNF-α及IL-8检测对COPD诊断和预后判断具有积极作用。 Objective:To evaluate the implication of TNF-α and IL-8 in chronic obstructive pulmonary disease(COPD).Methods:Serum levels of TNF-α and IL-8 were determined by ELISA in 28 patients with acutely exacerbated COPD,25 patients with stableCOPD and 30 healthy subjects served as contro1.PO2,PCO2 were assayed also,and the relationship among these parameters wasstatistically analyzed.Results:The serum TNF-α and IL-8 levels in acute exacerbated COPD were obviously higher than those in stableCOPD patients as well as the healthy controls;the stable COPD patients were obviously higher than that of the healthy controls.Furthermore,The serum TNF-α and IL-8 levels of acutely exacerbated COPD patients were negatively correlated with the PO2 andpositively correlated with PCO2.Conclusion:Serum TNF-α and IL-8 may participate in the airway inflammatory process of COPD.
出处 《现代医药卫生》 2010年第14期2106-2107,共2页 Journal of Modern Medicine & Health
关键词 慢性阻塞性肺疾病 肿瘤坏死因子Α 白介素-8 Chronic obstructive pulmonary disease TNF-α IL-8
  • 相关文献

参考文献3

二级参考文献24

  • 1许建英,赵鸣武,廖松林.Establishment and pathological study of models of chronic obstructive pulmonary disease by SO_2 inhalation method[J].Chinese Medical Journal,2000(3):21-24. 被引量:7
  • 2有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:280
  • 3GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
  • 4Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
  • 5Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.
  • 6冉丕鑫 王辰 姚婉贞 等.我国部分地区慢性阻塞性肺疾病流行病学研究[J].中华结核和呼吸杂志,2007,.
  • 7Bargon J, Muller U, Buhl R. COPD, a systemic disease-nutritional approaches[J]. Med Klin ( Munich), 2004, 99 (12) : 719 - 726.
  • 8Rutten EP, Franssen FM, Engelen MP, et al. Greater whole-body myofibrilliar protein breakdown in cachectic patients with chronic obstructive pulmonary disease [J]. Am J Clin Nutr, 2006,83 ( 4 ) : 829 - 834.
  • 9Man WDC, Moxham J, Polkey MI. Magnetic stimulation for the measurement of respiratory and skeletal muscle function [ J]. Eur Respir J, 2004,24(5): 846-860.
  • 10Schols AM. Nutritional and metabolic modulation in chronic obstructive pulmonary disease management[ J]. Eur Respir J Suppl, 2003, 46:81 s - 86s.

共引文献8246

同被引文献54

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部